Comments on: N4 Pharma: a consumer-driven reformulation and generics specialist https://ukinvestor.foxrobinson.com/n4-pharma-consumer-driven-reformulation-specialist/ Tue, 12 Nov 2019 18:03:24 +0000 hourly 1 https://wordpress.org/?v=6.6.2 By: Google https://ukinvestor.foxrobinson.com/n4-pharma-consumer-driven-reformulation-specialist/#comment-12558 Tue, 12 Nov 2019 18:03:24 +0000 https://ukinvestor.foxrobinson.com/?p=10358#comment-12558 Google

Check beneath, are some totally unrelated sites to ours, nonetheless, they are most trustworthy sources that we use.

]]> By: UK Investor Magazine – N4 Pharma: a consumer-driven reformulation and generics specialist - N4 Pharma https://ukinvestor.foxrobinson.com/n4-pharma-consumer-driven-reformulation-specialist/#comment-9856 Fri, 22 Mar 2019 08:37:37 +0000 https://ukinvestor.foxrobinson.com/?p=10358#comment-9856 […] N4 Pharma (LON:N4P) is a consumer-driven pharmaceutical company developing reformulations of a number of key drugs. These have the potential to produce very attractive returns for shareholders in the form of an estimated £300 million of sales if they achieve full commerciality… Read the full article at UK Investor Magazine. […]

]]> By: N4 pharma shares rise after Nuvec update - UK Investor Magazine https://ukinvestor.foxrobinson.com/n4-pharma-consumer-driven-reformulation-specialist/#comment-8726 Mon, 29 Oct 2018 11:30:12 +0000 https://ukinvestor.foxrobinson.com/?p=10358#comment-8726 […] Read more about our N4 Pharma stock analysis from February, here. […]

]]>